ANGO ANGIODYNAMICS INC
Nasdaq · SEC CIK 1275187 · EDGAR
- Bought, last 12 months
- $239.5K 3 purchases by 3 insiders
- Sold, last 12 months
- $344.0K 1 sales by 1 insiders
- Filings on record
- 190 since 2021-07-23, latest 2026-07-31 16:45
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Nighan Warren JR | SVP Quality, Regulatory | — | $344.0K |
| Weiss Lawrence T | SVP, CLO | $118.1K | — |
| Clemmer James C | Pres, CEO, Dir | $111.5K | — |
| Trowbridge Stephen A | EVP, CFO | $9,932 | — |
| Piccinini Laura | SVP International | — | — |
| Burgess Lorinda | Dir | — | — |
| Licitra Karen A | Dir | — | — |
| Campbell Chad Thomas | SVP, GM, Vascular Access | — | — |
| Tarnoff Michael E | Dir | — | — |
| Auen Eileen O'Shea | Dir | — | — |
Transactions 230
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-07-26 | 2023-07-19 | ANGO | Trowbridge Stephen A | EVP, CFO | M - OptEx | $0.00 | +8,769 | 123.4K | +8% | $0 |
| D | 2023-07-26 | 2023-07-19 | ANGO | Trowbridge Stephen A | EVP, CFO | F - Tax | $8.92 | -3,159 | 120.2K | -3% | -$28.2K |
| D | 2023-07-26 | 2023-07-19 | ANGO | Helsel Dave | SVP Gbl Ops, R, D | F - Tax | $8.92 | -1,575 | 31.1K | -5% | -$14.0K |
| D | 2023-07-26 | 2023-07-19 | ANGO | Helsel Dave | SVP Gbl Ops, R, D | M - OptEx | $0.00 | +4,371 | 32.7K | +15% | $0 |
| D | 2023-07-26 | 2023-07-19 | ANGO | Clemmer James C | Pres, CEO, Dir | M - OptEx | $0.00 | +31.6K | 560.6K | +6% | $0 |
| D | 2023-07-26 | 2023-07-19 | ANGO | Clemmer James C | Pres, CEO, Dir | F - Tax | $8.92 | -11.4K | 549.3K | -2% | -$101.5K |
| D | 2023-07-26 | 2023-07-19 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | F - Tax | $8.92 | -1,404 | 50.0K | -3% | -$12.5K |
| D | 2023-07-26 | 2023-07-19 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | M - OptEx | $0.00 | +3,900 | 51.4K | +8% | $0 |
| D | 2023-07-26 | 2023-07-19 | ANGO | Centea Scott | SVP, GM, VIT | M - OptEx | $0.00 | +3,415 | 61.5K | +6% | $0 |
| D | 2023-07-26 | 2023-07-19 | ANGO | Centea Scott | SVP, GM, VIT | F - Tax | $8.92 | -1,230 | 60.3K | -2% | -$11.0K |
| M | 2023-07-25 | 2023-07-20+ | ANGO | Piccinini Laura | SVP International | F - Tax | $8.70 | -1,029 | 19.5K | -5% | -$8,956 |
| M | 2023-07-25 | 2023-07-20+ | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | F - Tax | $8.69 | -754 | 47.5K | -2% | -$6,554 |
| M | 2023-07-25 | 2023-07-20+ | ANGO | Trowbridge Stephen A | EVP, CFO | F - Tax | $8.70 | -1,384 | 115.3K | -1% | -$12.0K |
| M | 2023-07-25 | 2023-07-20+ | ANGO | Centea Scott | SVP, GM, VIT | F - Tax | $8.70 | -588 | 58.4K | -1.0% | -$5,116 |
| M | 2023-07-25 | 2023-07-20+ | ANGO | Clemmer James C | Pres, CEO, Dir | F - Tax | $8.69 | -6,354 | 532.4K | -1% | -$55.2K |
| M | 2023-07-25 | 2023-07-20+ | ANGO | Helsel Dave | SVP Gbl Ops, R, D | F - Tax | $8.69 | -697 | 28.3K | -2% | -$6,059 |
| D | 2023-07-21 | 2023-07-19 | ANGO | Clemmer James C | Pres, CEO, Dir | A - Grant | $0.00 | +92.2K | 535.4K | +21% | $0 |
| 2023-07-21 | 2023-07-19 | ANGO | Auen Eileen O'Shea | Dir | A - Grant | $0.00 | +17.0K | 66.5K | +34% | $0 | |
| 2023-07-21 | 2023-07-19 | ANGO | DONNELLY HOWARD W | Dir | A - Grant | $0.00 | +17.0K | 128.8K | +15% | $0 | |
| D | 2023-07-21 | 2023-07-19 | ANGO | Helsel Dave | SVP Gbl Ops, R, D | A - Grant | $0.00 | +10.8K | 29.0K | +59% | $0 |
| 2023-07-21 | 2023-07-19 | ANGO | Meteny Dennis S | Dir | A - Grant | $0.00 | +17.0K | 140.0K | +14% | $0 | |
| D | 2023-07-21 | 2023-07-19 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | A - Grant | $0.00 | +11.4K | 48.3K | +31% | $0 |
| 2023-07-21 | 2023-07-19 | ANGO | Licitra Karen A | Dir | A - Grant | $0.00 | +17.0K | 52.2K | +48% | $0 | |
| D | 2023-07-21 | 2023-07-19 | ANGO | Piccinini Laura | SVP International | A - Grant | $0.00 | +14.2K | 20.1K | +238% | $0 |
| 2023-07-21 | 2023-07-19 | ANGO | REED JAN STERN | Dir | A - Grant | $0.00 | +17.0K | 66.8K | +34% | $0 | |
| D | 2023-07-21 | 2023-07-19 | ANGO | Trowbridge Stephen A | EVP, CFO | A - Grant | $0.00 | +28.7K | 116.0K | +33% | $0 |
| 2023-07-21 | 2023-07-19 | ANGO | JOHNSON WESLEY | Dir | A - Grant | $0.00 | +17.0K | 105.3K | +19% | $0 | |
| D | 2023-07-21 | 2023-07-19 | ANGO | Centea Scott | SVP, GM, VIT | A - Grant | $0.00 | +10.6K | 58.7K | +22% | $0 |
| 2023-07-21 | 2023-07-19 | ANGO | Tarnoff Michael E | Dir | A - Grant | $0.00 | +17.0K | 45.2K | +61% | $0 | |
| 2023-07-21 | 2023-07-19 | ANGO | Burgess Lorinda | Dir | A - Grant | $0.00 | +17.0K | 17.0K | New | $0 | |
| M | 2023-07-18 | 2023-07-14+ | ANGO | Centea Scott | SVP, GM, VIT | F - Tax | $9.60 | -868 | 48.1K | -2% | -$8,334 |
| M | 2023-07-18 | 2023-07-14+ | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | F - Tax | $9.61 | -875 | 37.2K | -2% | -$8,407 |
| M | 2023-07-18 | 2023-07-14+ | ANGO | Helsel Dave | SVP Gbl Ops, R, D | F - Tax | $9.61 | -992 | 18.5K | -5% | -$9,531 |
| M | 2023-07-18 | 2023-07-14+ | ANGO | Clemmer James C | Pres, CEO, Dir | F - Tax | $9.61 | -7,168 | 443.2K | -2% | -$68.9K |
| M | 2023-07-18 | 2023-07-14+ | ANGO | Trowbridge Stephen A | EVP, CFO | F - Tax | $9.61 | -1,738 | 87.7K | -2% | -$16.7K |
| 2023-06-02 | 2023-06-01 | ANGO | Piccinini Laura | SVP International | F - Tax | $9.64 | -1,400 | 5,954 | -19% | -$13.5K | |
| 2023-02-07 | 2023-02-01 | ANGO | ROSENZWEIG RICHARD C | SVP, GC | F - Tax | $13.36 | -1,137 | 15.7K | -7% | -$15.2K | |
| 2023-02-07 | 2023-02-03 | ANGO | Trowbridge Stephen A | EVP, CFO | F - Tax | $13.43 | -555 | 89.0K | -0.6% | -$7,454 | |
| 2023-02-01 | 2023-01-31 | ANGO | Helsel Dave | SVP Gbl Ops, R, D | S - Sale | $12.95 | -4,633 | 19.2K | -19% | -$60.0K | |
| 2022-10-12 | 2022-10-12 | ANGO | Trowbridge Stephen A | EVP, CFO | P - Purchase | $13.82 | +1,083 | 89.6K | +1% | +$15.0K | |
| 2022-10-11 | 2022-10-10 | ANGO | Clemmer James C | Pres, CEO, Dir | P - Purchase | $15.00 | +10.0K | 450.4K | +2% | +$150.0K | |
| 2022-08-01 | 2022-07-29 | ANGO | Helsel Dave | SVP Gbl Ops, R, D | S - Sale | $22.44 | -5,000 | 23.8K | -17% | -$112.2K | |
| D | 2022-07-22 | 2022-07-20 | ANGO | Clemmer James C | Pres, CEO, Dir | A - Grant | $0.00 | +33.1K | 440.4K | +8% | $0 |
| 2022-07-22 | 2022-07-20 | ANGO | Licitra Karen A | Dir | A - Grant | $0.00 | +7,060 | 35.2K | +25% | $0 | |
| D | 2022-07-22 | 2022-07-20 | ANGO | Nighan Warren JR | SVP Quality, Regulatory | A - Grant | $0.00 | +3,426 | 39.6K | +9% | $0 |
| D | 2022-07-22 | 2022-07-20 | ANGO | Helsel Dave | SVP Gbl Ops, R, D | A - Grant | $0.00 | +3,691 | 28.8K | +15% | $0 |
| 2022-07-22 | 2022-07-20 | ANGO | Meteny Dennis S | Dir | A - Grant | $0.00 | +7,060 | 123.0K | +6% | $0 | |
| D | 2022-07-22 | 2022-07-20 | ANGO | Centea Scott | SVP, GM, VIT | A - Grant | $0.00 | +3,705 | 49.0K | +8% | $0 |
| 2022-07-22 | 2022-07-20 | ANGO | DONNELLY HOWARD W | Dir | A - Grant | $0.00 | +7,060 | 111.8K | +7% | $0 | |
| 2022-07-22 | 2022-07-20 | ANGO | JOHNSON WESLEY | Dir | A - Grant | $0.00 | +7,060 | 88.3K | +9% | $0 | |
| D | 2022-07-22 | 2022-07-20 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | A - Grant | $0.00 | +3,987 | 37.8K | +12% | $0 |
| D | 2022-07-22 | 2022-07-20 | ANGO | ROSENZWEIG RICHARD C | SVP, GC | A - Grant | $0.00 | +3,963 | 16.9K | +31% | $0 |
| 2022-07-22 | 2022-07-20 | ANGO | Auen Eileen O'Shea | Dir | A - Grant | $0.00 | +7,060 | 49.5K | +17% | $0 | |
| D | 2022-07-22 | 2022-07-20 | ANGO | Trowbridge Stephen A | EVP, CFO | A - Grant | $0.00 | +7,961 | 88.5K | +10% | $0 |
| D | 2022-07-22 | 2022-07-20 | ANGO | Piccinini Laura | SVP International | A - Grant | $0.00 | +4,402 | 7,354 | +149% | $0 |
| 2022-07-22 | 2022-07-20 | ANGO | Tarnoff Michael E | Dir | A - Grant | $0.00 | +7,060 | 28.1K | +34% | $0 | |
| 2022-07-22 | 2022-07-20 | ANGO | REED JAN STERN | Dir | A - Grant | $0.00 | +7,060 | 49.8K | +17% | $0 | |
| D | 2022-07-18 | 2022-07-15 | ANGO | JOHNSON WESLEY | Dir | M - OptEx | $15.95 | +6,022 | 85.7K | +8% | +$96.1K |
| D | 2022-07-18 | 2022-07-15 | ANGO | JOHNSON WESLEY | Dir | F - Tax | $21.32 | -4,505 | 81.2K | -5% | -$96.0K |
| D | 2022-07-18 | 2022-07-15 | ANGO | Trowbridge Stephen A | EVP, CFO | F - Tax | $21.32 | -12.4K | 80.5K | -13% | -$264.3K |
| D | 2022-07-18 | 2022-07-15 | ANGO | Trowbridge Stephen A | EVP, CFO | M - OptEx | $15.95 | +14.8K | 92.9K | +19% | +$235.4K |
| D | 2022-07-14 | 2022-07-12 | ANGO | Meteny Dennis S | Dir | M - OptEx | $15.95 | +6,022 | 120.7K | +5% | +$96.1K |
| D | 2022-07-14 | 2022-07-12 | ANGO | Meteny Dennis S | Dir | F - Tax | $20.02 | -4,798 | 115.9K | -4% | -$96.1K |
| D | 2022-07-11 | 2022-07-07 | ANGO | Nighan Warren JR | SVP Quality, Regulatory | M - OptEx | $0.00 | +3,233 | 37.1K | +10% | $0 |
| D | 2022-07-11 | 2022-07-07 | ANGO | Nighan Warren JR | SVP Quality, Regulatory | F - Tax | $20.54 | -919 | 36.2K | -2% | -$18.9K |
| D | 2022-07-11 | 2022-07-07 | ANGO | Trowbridge Stephen A | EVP, CFO | F - Tax | $20.54 | -1,509 | 78.2K | -2% | -$31.0K |
| D | 2022-07-11 | 2022-07-07 | ANGO | Trowbridge Stephen A | EVP, CFO | M - OptEx | $0.00 | +4,188 | 79.7K | +6% | $0 |
| D | 2022-07-11 | 2022-07-07 | ANGO | Clemmer James C | Pres, CEO, Dir | M - OptEx | $0.00 | +25.1K | 415.9K | +6% | $0 |
| D | 2022-07-11 | 2022-07-07 | ANGO | Clemmer James C | Pres, CEO, Dir | F - Tax | $20.54 | -8,574 | 407.3K | -2% | -$176.1K |
| D | 2022-07-11 | 2022-07-07 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | M - OptEx | $0.00 | +3,104 | 34.8K | +10% | $0 |
| D | 2022-07-11 | 2022-07-07 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | F - Tax | $20.54 | -1,078 | 33.8K | -3% | -$22.1K |
| D | 2022-07-11 | 2022-07-07 | ANGO | Helsel Dave | SVP Gbl Ops, R, D | M - OptEx | $0.00 | +3,480 | 26.4K | +15% | $0 |
| D | 2022-07-11 | 2022-07-07 | ANGO | Helsel Dave | SVP Gbl Ops, R, D | F - Tax | $20.54 | -1,223 | 25.1K | -5% | -$25.1K |
| 2022-05-02 | 2022-04-28 | ANGO | Helsel Dave | SVP Gbl Ops, R, D | S - Sale | $22.44 | -3,513 | 22.9K | -13% | -$78.8K | |
| D | 2022-04-21 | 2022-04-20 | ANGO | DONNELLY HOWARD W | Dir | M - OptEx | $15.95 | +6,022 | 104.7K | +6% | +$96.1K |
| M | 2022-04-13 | 2022-04-11+ | ANGO | JOHNSON WESLEY | Dir | S - Sale | $23.05 | -7,500 | 79.7K | -9% | -$172.8K |
| 2022-02-04 | 2022-02-03 | ANGO | Trowbridge Stephen A | EVP, CFO | F - Tax | $20.48 | -583 | 75.5K | -0.8% | -$11.9K | |
| 2022-02-03 | 2022-02-01 | ANGO | ROSENZWEIG RICHARD C | SVP, GC | F - Tax | $21.31 | -1,194 | 12.9K | -8% | -$25.4K | |
| 2022-01-12 | 2022-01-12 | ANGO | Trowbridge Stephen A | EVP, CFO | P - Purchase | $22.64 | +1,000 | 76.1K | +1% | +$22.6K | |
| 2022-01-12 | 2022-01-11 | ANGO | Clemmer James C | Pres, CEO, Dir | P - Purchase | $22.84 | +10.0K | 390.8K | +3% | +$228.4K | |
| DA | 2021-12-30 | 2021-07-21 | ANGO | Clemmer James C | Pres, CEO, Dir | A - Grant | $0.00 | +37.4K | 372.5K | +11% | $0 |
| 2021-11-05 | 2021-10-31 | ANGO | Centea Scott | SVP, GM, Gbl VIT | F - Tax | $29.37 | -953 | 45.3K | -2% | -$28.0K | |
| 2021-10-21 | 2021-10-20 | ANGO | Helsel Dave | SVP Gbl Ops, R, D | S - Sale | $27.97 | -3,494 | 26.4K | -12% | -$97.7K | |
| D | 2021-10-21 | 2021-07-21 | ANGO | Piccinini Laura | SVP International | A - Grant | $0.00 | +2,952 | 2,952 | New | $0 |
| D | 2021-10-18 | 2021-10-15 | ANGO | Centea Scott | SVP, GM, Gbl VIT | S - Sale+OE | $27.92 | -12.0K | 46.2K | -21% | -$335.0K |
| D | 2021-10-18 | 2021-10-15 | ANGO | Centea Scott | SVP, GM, Gbl VIT | M - OptEx | $16.77 | +12.0K | 58.2K | +26% | +$201.2K |
| D | 2021-10-06 | 2021-10-05 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | S - Sale+OE | $27.15 | -10.7K | 31.7K | -25% | -$291.8K |
| D | 2021-10-06 | 2021-10-05 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | M - OptEx | $16.59 | +10.7K | 42.5K | +34% | +$178.3K |
| DA | 2021-08-18 | 2021-08-12 | ANGO | Trowbridge Stephen A | EVP, CFO | F - Tax | $27.29 | -4,173 | 75.1K | -5% | -$113.9K |
| DA | 2021-08-18 | 2021-08-12 | ANGO | Trowbridge Stephen A | EVP, CFO | M - OptEx | $0.00 | +10.9K | 79.3K | +16% | $0 |
| DA | 2021-08-18 | 2021-08-12 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | M - OptEx | $0.00 | +8,210 | 34.9K | +31% | $0 |
| DA | 2021-08-18 | 2021-08-12 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | F - Tax | $27.29 | -3,130 | 31.7K | -9% | -$85.4K |
| DA | 2021-08-18 | 2021-08-12 | ANGO | Clemmer James C | Pres, CEO, Dir | M - OptEx | $0.00 | +40.5K | 399.7K | +11% | $0 |
| DA | 2021-08-18 | 2021-08-12 | ANGO | Clemmer James C | Pres, CEO, Dir | F - Tax | $27.29 | -21.5K | 378.2K | -5% | -$587.6K |
| DA | 2021-08-18 | 2021-08-12 | ANGO | Helsel Dave | SVP Gbl Ops, R, D | M - OptEx | $0.00 | +11.4K | 33.2K | +52% | $0 |
| DA | 2021-08-18 | 2021-08-12 | ANGO | Helsel Dave | SVP Gbl Ops, R, D | F - Tax | $27.29 | -3,347 | 29.9K | -10% | -$91.3K |
| D | 2021-08-17 | 2021-08-12 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | M - OptEx | $0.00 | +2,395 | 29.1K | +9% | $0 |
| D | 2021-08-17 | 2021-08-12 | ANGO | Campbell Chad Thomas | SVP, GM, Vascular Access | F - Tax | $27.29 | -702 | 28.4K | -2% | -$19.2K |
| D | 2021-08-17 | 2021-08-12 | ANGO | Helsel Dave | SVP Gbl Ops, R, D | M - OptEx | $0.00 | +2,685 | 24.5K | +12% | $0 |
| D | 2021-08-17 | 2021-08-12 | ANGO | Helsel Dave | SVP Gbl Ops, R, D | F - Tax | $27.29 | -788 | 23.7K | -3% | -$21.5K |
Purchase Sale Sale after option exercise All abbreviations